当前位置:首页 - 行情中心 - 宏源药业(301246) - 财务分析 - 现金流量表

宏源药业

(301246)

  

流通市值:24.28亿  总市值:65.20亿
流通股本:1.49亿   总股本:4.00亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金146,684,493.281,366,218,484.66940,482,271.13490,522,106.95
收到的税费返还10,750,121.8831,797,151.6329,566,068.9717,880,703.28
收到其他与经营活动有关的现金4,880,353.2342,653,488.226,278,009.9324,118,263.91
经营活动现金流入的平衡项目0000
经营活动现金流入小计162,314,968.391,440,669,124.49996,326,350.03532,521,074.14
购买商品、接受劳务支付的现金175,212,750.571,039,473,338.51635,336,979.13453,546,735.58
支付给职工以及为职工支付的现金56,653,620.96195,123,016.15139,778,207.79101,654,576.45
支付的各项税费5,837,821.2698,936,419.0867,939,701.7458,681,127.61
支付其他与经营活动有关的现金14,108,443.5371,885,952.0143,755,048.628,922,547.54
经营活动现金流出的平衡项目0000
经营活动现金流出小计251,812,636.321,405,418,725.75886,809,937.26642,804,987.18
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-89,497,667.9335,250,398.74109,516,412.77-110,283,913.04
二、投资活动产生的现金流量:
收回投资收到的现金1,285,144,751.733,178,274,785.211,916,000,000-
取得投资收益收到的现金61,500,00041,000,00010,635,991.88-
处置固定资产、无形资产和其他长期资产收回的现金净额75,199.821,139,579.52428,693.01357,778.33
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,346,719,951.553,220,414,364.731,927,064,684.89357,778.33
购建固定资产、无形资产和其他长期资产支付的现金132,510,810.67474,640,601.41266,989,871.68165,634,571.16
投资支付的现金957,000,0004,815,000,0003,072,980,0001,996,000,000
支付其他与投资活动有关的现金--290,000,000-
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,089,510,810.675,289,640,601.413,629,969,871.682,161,634,571.16
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额257,209,140.88-2,069,226,236.68-1,702,905,186.79-2,161,276,792.83
三、筹资活动产生的现金流量:
吸收投资收到的现金-2,195,843,746.632,195,843,746.632,195,843,746.63
取得借款收到的现金-21,253,147.0725,000,00025,000,000
收到其他与筹资活动有关的现金2,248,928.2993,013,676.5590,200,000120,547,552.79
筹资活动现金流入平衡项目0000
筹资活动现金流入小计2,248,928.292,310,110,570.252,311,043,746.632,341,391,299.42
偿还债务支付的现金2,777,00097,554,00072,554,00069,777,000
分配股利、利润或偿付利息支付的现金2,905,843.9353,801,520.9649,355,564.542,246,823.3
支付其他与筹资活动有关的现金-5,664,573.3510,351,867.341,572,500
筹资活动现金流出平衡项目0000
筹资活动现金流出小计5,682,843.93157,020,094.31132,261,431.84113,596,323.3
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-3,433,915.642,153,090,475.942,178,782,314.792,227,794,976.12
四、汇率变动对现金及现金等价物的影响1,290,060.81570,348.75744,354.04324,789.17
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额165,567,618.12119,684,986.75586,137,894.81-43,440,940.58
加:期初现金及现金等价物余额356,404,485.2236,719,498.45236,719,498.45236,719,498.45
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额521,972,103.32356,404,485.2822,857,393.26193,278,557.87
补充资料:
净利润-87,168,626.24-65,023,439.88
资产减值准备-30,891,413.59-15,303,179.16
固定资产和投资性房地产折旧-151,024,066.94-64,690,302.91
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-151,024,066.94-64,690,302.91
无形资产摊销-5,133,346.08-2,558,926.29
长期待摊费用摊销-4,441,206.62-2,246,176.83
处置固定资产、无形资产和其他长期资产的损失--568,537.69--357,778.33
公允价值变动损失--2,860,235.62--11,155,991.87
财务费用-13,015,342.99-419,783.65
投资损失--18,132,500.53-6,485,605.07
递延所得税-3,890,098.95-5,164,010.56
其中:递延所得税资产减少-3,662,641.9-5,254,909.42
递延所得税负债增加-227,457.05--90,898.86
存货的减少-135,060,617.24-95,913,374.92
经营性应收项目的减少--152,749,168.35--33,619,398.21
经营性应付项目的增加--221,783,373.89--323,315,291.99
现金的期末余额-356,404,485.2-193,278,557.87
减:现金的期初余额-236,719,498.45-236,719,498.45
公告日期2024-04-232024-04-232023-10-282023-08-31
审计意见(境内)标准无保留意见
TOP↑